Evidence map›Paper›PMID 19730859›Full record

ArticleCancer immunology, immunotherapy : CII2010

Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression.

Olga Radkevich-Brown, Marie P Piechocki, Jessica B Back, Amy M Weise, Shari Pilon-Thomas, Wei-Zen Wei

Open access · greenAbstract readEvaluation Study
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Novel Mouse Models for Cancer Immunology.Annual review of cancer biology · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Cancer vaccines.BMJ (Clinical research ed.) · 2015
    Review
  12. Oncoimmunology · 2015
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Olga Radkevich-BrownKarmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA.
Marie P Piechocki
Jessica B Back
Amy M Weise
Shari Pilon-Thomas
Wei-Zen Wei
The Barbara Ann Karmanos Cancer Institute · USWayne State University · US

Funding

DEVELOPMENT OF ERBB2 BASED BREAST CANCER VACCINESR01CA076340 · NCI · WAYNE STATE UNIVERSITY · PI WEI, WEI-ZEN · 1998 to 2020
$5.2M
Tilting the balance in cancer immunotherapy and autoimmunityR01CA125680 · NCI · WAYNE STATE UNIVERSITY · PI WEI, WEI-ZEN · 2006 to 2010
$1.3M
NCI NIH HHS CA125680NCI NIH HHS CA76340NCI NIH HHS R01 CA076340NCI NIH HHS R01 CA125680
6 · The paper itself

Abstract

In situ expression of a foreign antigen and an immune-modulating cytokine by intratumoral DNA electroporation was tested as a cancer therapy regimen. Transgene expression in the tumors was sustained for 2-3 weeks after intratumoral electroporation with mammalian expression plasmid containing firefly luciferase cDNA. Electroporation with cDNA encoding tetanus toxin fragment C (TetC) induced tetanus toxin-binding antibody, demonstrating immune recognition of the transgene product. Intratumoral electroporation with TetC and IL-12 cDNA after mice were treated with CD25 mAb to remove regulatory T cells induced IFN-gamma producing T-cell response to tumor-associated antigen, heavy inflammatory infiltration, regression of established tumors and immune memory to protect mice from repeated tumor challenge. Intratumoral expression of immune-modulating molecules may be most suitable in the neoadjuvant setting to enhance the therapeutic efficacy and provide long-term protection.

Indexed as

AnimalsCancer VaccinesElectroporationGene ExpressionImmunologic MemoryInterleukin-12Lymphocyte ActivationMiceMice, Inbred BALB CNeoplasmsPeptide FragmentsTetanus ToxinT-Lymphocytes, RegulatoryTransfectionTransgenesVaccines, DNACancer VaccinesInterleukin-12Peptide FragmentsTetanus Toxintetanus toxin fragment CVaccines, DNA

Identifiers

PMID19730859
PMCPMC3702174
OpenAlexW2048292015

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.